Sign In | Join Free | My himfr.com
Home > Troponin I Kit >

New Products CTnI Cardiac Troponin I Kit Fluorescence Immunoassay For IVD Device

WWHS Biotech.Inc(exclusive marketed by Dawin)
Contact Now
    Buy cheap New Products CTnI Cardiac Troponin I Kit Fluorescence Immunoassay For IVD Device from wholesalers
     
    Buy cheap New Products CTnI Cardiac Troponin I Kit Fluorescence Immunoassay For IVD Device from wholesalers
    • Buy cheap New Products CTnI Cardiac Troponin I Kit Fluorescence Immunoassay For IVD Device from wholesalers
    • Buy cheap New Products CTnI Cardiac Troponin I Kit Fluorescence Immunoassay For IVD Device from wholesalers

    New Products CTnI Cardiac Troponin I Kit Fluorescence Immunoassay For IVD Device

    Ask Lasest Price
    Brand Name : WWHS
    Model Number : cTnI
    Certification : CE
    Price : Negotiable
    Payment Terms : T/T
    Supply Ability : 50000 Kits per Week
    Delivery Time : 7 Days
    • Product Details
    • Company Profile

    New Products CTnI Cardiac Troponin I Kit Fluorescence Immunoassay For IVD Device

    [Product Name] cTnI.pdf

    Cardiac Troponin I (cTnI) Rapid Quantitative Test(Fluorescence immunoassay)


    The product should be stored at 4℃-30℃ in a dry and dark place, sealed using aluminum foil bag and must not be frozen. The storage life is 12 months. The test card should be unpacked at room temperature (15℃-30℃) and should be used in 15min after unpacked at a temperature of (15-30)℃ and relative humidity of 20%-90%.

    See outer packing for production date, batch number and expiry date.


    [Limitation of Test Method]

    1. The kit can be used to test serum/plasma/whole blood specimens of human body only.

    2. Due to limitations of serological methods for antigen and antibody response, the test result cannot be used as the only basis for clinical diagnosis and should be evaluated together with all existing clinical and experimental data.

    3. The content of triglyceride contained in the sample is no more than 15mg/mL, that of hemoglobin is no more than 5mg/mL and that of hemoglobin is no more than 0.5mg/mL, and the relative deviation is limited to ±15%.

    4. When cTnI concentration of samples is less than 250ng/mL, Hook effect is not observed.

    1. When human anti mouse concentration of samples is less than 50ng/mL, HAMA effect will not be observed.
    2. When RF concentration of samples is less than 2000IU/mL, relative deviation of test result is limited to ±15%.

    [Precautions]

    1. Test card and buffer solution are single-use and they cannot be reused.
    2. Please inspect packaging integrity and validity of kit before use and then unpack the product. If the product is stored at low temperature, restore to room temperature (15℃-30℃) before unpacking and use. Reagent cannot be used if packaging is damaged and the validity period expires.
    3. Take the test card out of the aluminum foil bag and carry out experiment in 15min. Do not place it in the air for a long time to avoid dampness.
    4. It is required to strictly comply with the requirements for sample collection and storage. If the sample is turbid, please centrifuge and precipitate it before use.
    5. The kit contains products from animals. Eligible information about animal source and sanitary condition cannot absolutely ensure inexistence of infectious pathogen. Therefore, these products should be disposed of as latent infective material, and all samples, reagents and latent contaminants should be disinfected and disposed of according to relevant local regulations.
    6. Too high or too low hematocrit of red cells may affect whole blood test result, so verification should be conducted using other methods .

    Remark

    1, Room temperature store and transport, shelf life 12 months.

    2,After dissolved, should store at -20℃, shelf life 1 month.

    3,Each unit for 10 tests.


    Assay list     
    Cardiac     
    cat#.Product itemSpecimenReaction TimeMeasure RangeClinical RangeItended Use
    1cTnIWB/Serum/Plasma12min.0.1-40ng/ml<0.3ng/mlseveral heart diseases including myocardial infarction and heart failure.
    2MyoWB/Serum/Plasma12min.5-400ng/ml<58ng/mlacute myocardial infarction (AMI) in early stage.
    3CK-MBWB/Serum/Plasma12min.1-200ng/ml<5ng/mlacute myocardial infarction (AMI) in early stage.
    4NT-proBNPWB/Serum/Plasma10min.20-35000pg/mlUnder 75:0~347pg/mL,
    Over 75:0~449pg/mL
    heart failure .
    5D-DimerWB/Plasma10min.40-10000ng/ml<500ng/mldisseminated intravascular coagulation (DIC),deep vein thrombosis (DVT),pulmonary embolism (PE), myocardial infarction, cerebral infarction, etc.
    6cTnI+Myo+CKMBWB/Serum/Plasma12min.same with single itemsame with single itemTriple marker of myocardial infarction.
    7ST2WB/Serum/Plasma10min.10-400ng/ml<35ng/mlheart failure .
    8Lp-PLA2WB/Serum/Plasma10min.10-900ng/ml<175ng/mlRisk evaluation of ACS and atherosclerotic ischemic stroke patients.
    9S100-βWB/Serum/Plasma10min.0.05-10ng/ml<0.2ng/mlCerebral infarction, cerebral injury.
    Inflammation     
    10CRP / hs-CRPWB/Serum/Plasma3min.0.5-200mg/LCRP<10mg/L,hs-CRP<1mg/Lnonspecficity inflammatory marker.
    11SAASerum5min.1-200mg/L<10mg/Linflammation&infection.
    12PCTWB/Serum/Plasma10min.0.2-100ng/ml<0.5ng/mlSepsis
    13CRP+SAAWB/Serum/Plasma5min.same with single itemsame with single iteminflammation&infection.
    14IL-6WB/Serum/Plasma10min.5-4000pg/ml10pg/mldiabetes,rheumatoid arthritis,etc
    Thyroid Hormone     
    15TSHSerum/Plasma15min.0.3-100mU/L0.35-5mU/Lhyperthyroidism and hypothyroidism
    16TT3Serum/Plasma15min.0.5-10nmol/L1.3-3.1nmol/Lthyroid dysfunction
    17TT4Serum/Plasma15min.5-300nmol/L66-181nmol/Lthyroid dysfunction
    18FT3Serum/Plasma15min.1-100pmol/L4-10pmol/Lthyroid dysfunction
    19FT4Serum/Plasma15min.5-300pmol/L19-39pmol/Lthyroid dysfunction
    Tumor Maker     
    20AFPSerum/Plasma15min.2.5-200ng/ml<20ng/mlpregnancy cancer
    21CEASerum/Plasma15min.1-200ng/ml<5ng/mlcolon cancer, colorectal cancer,etc.
    22NSESerum/Plasma15min.1-400ng/ml<16ng/mlnon-small cell lung cancer
    23FOBfecal specimens10min.50-1000ng/ml<100ng/mlAbnormal recessive gastrointestinal bleeding
    24PG IISerum/Plasma15min.1-100ug/LPGI/PGII>3.0gastric abnormalities
    25PG ISerum/Plasma15min.2.5-200ug/L>70ng/mlgastric abnormalities
    26TPSASerum/Plasma15min.0.5-40ng/ml<4ng/mlprostate cancer
    27FPSASerum/Plasma15min.0.1-10ng/ml<1ng/mlprostate cancer
    28CA12-5Serum/Plasma15min.20-500U/ml<35U/mlovarian cancer
    29CA15-3Serum/Plasma15min.10-400U/ml< 25 U/mLbreast cancer
    30HE4Serum/Plasma15min.50-2000pmol/L<140 pmol/Lovarian cancer
    31CA19-9Serum/Plasma15min.10-400U/ml< 27 U/mLpancreatic cancer
    32β-HCGSerum/Plasma15min.5-400mIU/ml<10 mIU/mLEarly pregrancy, ectopic HCG cancer,incomplete abortion
    33CK19(Cyfra21-1)Serum/Plasma15min.0.5-50ng/ml<2.5ng/mlnon-small cell lung cancer
    Fertility     
    34HCG / β-HCGSerum/Plasma10min.5-20000mIU/ml<5 mIU/mLearly pregrancy.
    35AMHSerum/Plasma10min.0.1-16ng/mlMale: 20-60 years old, 0.92-13.89 ng/mL
    Female: 20-29 years old, 0.88-10.35 ng/mL
    30-39 years old, 0.31-7.86 ng/mL 40 -50 years old, <5. 07 ng/mL
    ovarian reserve level
    Gastrointestinal      
    36FOBfecal specimens10min.qualitativequalitativegastrointestinal hemorrhage.
    37TRFfecal specimens10min.qualitativequalitativegastrointestinal hemorrhage.
    38FOB+TRFfecal specimens10min.qualitativequalitativegastrointestinal hemorrhage.
    Infection      
    39C.PneumoniaWB/Serum/Plasma15min.qualitativequalitativeCP infection
    40M.PneumoniaWB/Serum/Plasma15min.qualitativequalitativeMP infection
    41Covid-19 Antigennasal swab, throat swab or nasal wash/aspirate specimens15min.qualitativequalitativerespiratory tract
    42Covid-19 Ab IgG/IgMWB/Serum/Plasma15min.qualitativequalitativerespiratory tract
    43FluAnasal swab, throat swab or nasal wash/aspirate specimens15min.qualitativequalitativerespiratory tract
    44FluBnasal swab, throat swab or nasal wash/aspirate specimens15min.qualitativequalitativerespiratory tract
    Renal Injury      
    45CysCWB/Serum/Plasma5min.0.4-9mg/L0.5-1.1mg/Lrenal function
    46NGALUrine10min.10-1500ng/mL<132ng/mLacute kidney injury.
    Other      
    47FERRSerum5min.10-500ng/mlMale:24ng/mL~335ng/mL,
    Female:11ng/mL~307ng/mL
    iron metabolism related diseases, such as hemochromatosis and iron deficiency anemia
    48HbA1cWB10min.4%-14%4%-6%diabetes
    49VDSerum/Plasma15min.8-70ng/mL19-57ng/mLfetation

    Quality New Products CTnI Cardiac Troponin I Kit Fluorescence Immunoassay For IVD Device for sale
    Inquiry Cart 0
    Send your message to this supplier
     
    *From:
    *To: WWHS Biotech.Inc(exclusive marketed by Dawin)
    *Subject:
    *Message:
    Characters Remaining: (0/3000)